Amirpasha Moetazedian Invites a PHD Student to His Lab to Explore Sustainable Artificial Blood Vessels
Amirpasha Moetazedian, Lecturer in Medical Engineering at University of Hull, shared on LinkedIn:
”Funded 4-year PhD – Sustainable Artificial Blood Vessels (Home students only)
I’m looking for a motivated and dedicated UK/Home student to join my lab at the University of Hull on a fully funded 4-year PhD, offered through the BBSRC Yorkshire Bioscience Doctoral Training Partnership (YBDTP).
The project, “Development and validation of next-generation sustainable artificial blood vessels for modelling cardiovascular diseases”, will develop sustainable, microfluidic and bioprinted blood vessel models to study cardiovascular disease and thrombosis under flow.
You’ll gain experience in:
– Advanced biomaterials and bioink development
– Microfluidics and organ-on-a-chip
– Bioreactor design and vascular biomechanics
– Collaboration with industry (Jellagen®)
You’ll be supervised by a multidisciplinary team: myself and Dr Sarah Crossland from Medical Engineering at the University of Hull, Dr Simon Calaminus from Hull York Medical School, and Dr Vanessa L Hearnden from the University of Sheffield.
You will receive joint training at the University of Hull and the University of Sheffield.
Application deadline: 7 January 2026. Don’t miss out!
If you have any questions, get in touch with me at [email protected]
Eligibility: UK/Home students only
Host institution: University of Hull
More info and how to apply.
Please share or tag anyone who might be interested!”
Stay updated with Hemostasis Today.
-
Nov 24, 2025, 10:25Jean Jacques Kiladjian Visits INSERM-supervised CIC 1408 Investigation Center
-
Nov 24, 2025, 09:41Kamran Hajiyev Reflects on A Week of Innovation, Collaboration, and Scientific Exchange at SVIN 2025
-
Nov 24, 2025, 02:55Do You Know Why Clot Contracts? Marin Pavlov Reflects on Expert PE Conference 2025
-
Nov 24, 2025, 01:39Ashkan Shoamanesh Shares OCEANIC-STROKE Trial’s Successful Endpoints
-
Nov 24, 2025, 01:10Swarsat K Nath on HemeNext 2025: AI is Real, Measurable, and Already Changing Lives
-
Nov 23, 2025, 15:15Dirk Sibbing on OCEANIC-STROKE Demonstrationg Superiority of Asundexian vs. Placebo
-
Nov 23, 2025, 14:57Jesse Landry on SeraGene Therapeutics: Rewriting the Rules of Blood and Bleeding Disorders
-
Nov 23, 2025, 14:49Reza Shojaei: What Truly Motivates Donors And What Keeps Them Coming Back?
-
Nov 23, 2025, 14:48Michael Davidson: Why LDL Alone Isn’t Enough for CV Risk Reduction